Long acting GLP-1 receptor agonist (injectable)

Ecnoglutide 0.2 mg injection once weekly

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ECNO_SC_0p2MG_QW

Mechanism: GLP-1 receptor agonist; daily or weekly (liraglutide; dulaglutide; semaglutide; exenatide extended release; albiglutide; efpeglenatide; loxenatide; taspoglutide and others)
Trials: 0
Participants in these arms: 0

All doses pooled: Ecnoglutide injection
Ecnoglutide 1.2 mg injection once weekly
Ecnoglutide 0.6 mg injection once weekly
Ecnoglutide 0.4 mg injection once weekly
Ecnoglutide 0.1 mg injection
Ecnoglutide flexible dose injection
Ecnoglutide flexible dose injection
Ecnoglutide flexible dose injection
Ecnoglutide 0.6 mg injection
Ecnoglutide 0.8 mg injection once weekly

Ecnoglutide 0.2 mg injection once weekly

Related

Trials